WNY Asset Management LLC Buys New Position in iShares Biotechnology ETF (NASDAQ:IBB)

WNY Asset Management LLC purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,483 shares of the financial services provider’s stock, valued at approximately $203,000.

A number of other hedge funds have also modified their holdings of the company. NTV Asset Management LLC boosted its position in shares of iShares Biotechnology ETF by 1.2% in the first quarter. NTV Asset Management LLC now owns 53,606 shares of the financial services provider’s stock worth $7,356,000 after purchasing an additional 610 shares during the period. Highland Capital Management LLC purchased a new stake in iShares Biotechnology ETF during the first quarter valued at $226,000. PFG Advisors increased its position in iShares Biotechnology ETF by 3.9% during the first quarter. PFG Advisors now owns 4,655 shares of the financial services provider’s stock valued at $639,000 after acquiring an additional 173 shares during the last quarter. Oppenheimer & Co. Inc. increased its position in iShares Biotechnology ETF by 7.6% during the first quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock valued at $4,905,000 after acquiring an additional 2,532 shares during the last quarter. Finally, SG Americas Securities LLC grew its holdings in shares of iShares Biotechnology ETF by 27.6% in the first quarter. SG Americas Securities LLC now owns 14,074 shares of the financial services provider’s stock worth $1,931,000 after purchasing an additional 3,044 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.1 %

IBB stock traded up $0.12 during trading on Monday, hitting $145.15. The company had a trading volume of 1,352,750 shares, compared to its average volume of 1,627,806. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $146.34. The company has a 50 day simple moving average of $136.48 and a 200-day simple moving average of $135.32.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.